JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Klaassen, C. D.
Right arrow Articles by Plaa, G. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klaassen, C. D.
Right arrow Articles by Plaa, G. L.
Journal of Pharmacology And Experimental Therapeutics, Vol. 161, Issue 2, 361-366, 1968
Copyright © 1968 by American Society for Pharmacology and Experimental Therapeutics


STUDIES ON THE MECHANISM OF PHENOBARBITAL-ENHANCED SULFOBROMOPHTHALEIN DISAPPEARANCE

Curtis D. Klaassen 1 and Gabriel L. Plaa 1

1 Oakdale Toxicology Center, Department of Pharmacology, College of Medicine, The University of Iowa, Iowa City, Iowa

Increased plasma disappearance of sulfobromophthalein (BSP) was demonstrated after rats were treated with phenobarbital (75 mg/kg) once daily for 3 days. Since BSP undergoes storage, metabolism and excretion by the liver, these parameters were examined to determine which process or processes are altered by treatment with phenobarbital. No change in hepatic storage was demonstrated, but significant increases of in vitro metabolism, biliary transport maximum and bile flow were observed. With a dibrominated analog of BSP, phenol-3,6-dibromphthalein disulfonate (DBSP), and indocyanine green, which apparently are not biotransformed before their excretion, an enhanced plasma disappearance was also exhibited after phenobarbital treatment. With DBSP no significant alteration in hepatic storage was demonstrated, but an enhanced biliary transport maximum and bile flow were demonstrated. The data support the view that the enhanced biliary excretion of these dyes is an important factor after phenobarbital treatment and that the role of increased biotransformation is not as important for the enhanced plasma disappearance of these dyes as might be expected from the effect of phenobarbital on the biologic half-life of other substances.

Submitted on November 8, 1967
Accepted on February 12, 1968




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
N. J. Cherrington, A. L. Slitt, J. M. Maher, X.-X. Zhang, J. Zhang, W. Huang, Y.-J. Y. Wan, D. D. Moore, and C. D. Klaassen
INDUCTION OF MULTIDRUG RESISTANCE PROTEIN 3 (MRP3) IN VIVO IS INDEPENDENT OF CONSTITUTIVE ANDROSTANE RECEPTOR
Drug Metab. Dispos., November 1, 2003; 31(11): 1315 - 1319.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
N. Li, D. P. Hartley, N. J. Cherrington, and C. D. Klaassen
Tissue Expression, Ontogeny, and Inducibility of Rat Organic Anion Transporting Polypeptide 4
J. Pharmacol. Exp. Ther., May 1, 2002; 301(2): 551 - 560.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
N. J. Cherrington, D. P. Hartley, N. Li, D. R. Johnson, and C. D. Klaassen
Organ Distribution of Multidrug Resistance Proteins 1, 2, and 3 (Mrp1, 2, and 3) mRNA and Hepatic Induction of Mrp3 by Constitutive Androstane Receptor Activators in Rats
J. Pharmacol. Exp. Ther., January 1, 2002; 300(1): 97 - 104.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G. L. Guo, S. Choudhuri, and C. D. Klaassen
Induction Profile of Rat Organic Anion Transporting Polypeptide 2 (oatp2) by Prototypical Drug-Metabolizing Enzyme Inducers That Activate Gene Expression through Ligand-Activated Transcription Factor Pathways
J. Pharmacol. Exp. Ther., January 1, 2002; 300(1): 206 - 212.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1968 by the American Society for Pharmacology and Experimental Therapeutics.